Purchases and Sales Made in Q3 2022 in Aerovate Therapeutics, Inc. (AVTE)
This table provides information about the institutional ownership of Aerovate Therapeutics, Inc. (AVTE) during Q3 2022. The information is specifically focused on institutions that hold shares of Aerovate Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Cormorant Asset Management, LP
Boston, MA |
BUY
|
- |
600K+ 34.67% |
$8.86M - $15.5M
|
2.33M
$6.06M
|
|
Nov 14, 2022
Q3 2022
|
Orbimed Advisors LLC
San Diego, CA |
BUY
|
- |
316K+ 66.12% |
$4.67M - $8.16M
|
795K
$2.07M
|
|
May 15, 2023
Q3 2022
|
Vr Adviser, LLC
New York, NY |
BUY
|
- |
244K+ 41.25% |
$3.6M - $6.28M
|
834K
$2.17M
|
|
Nov 14, 2022
Q3 2022
|
Vr Adviser, LLC
New York, NY |
BUY
|
- |
244K+ 41.25% |
$3.6M - $6.28M
|
834K
$2.17M
|
|
Nov 14, 2022
Q3 2022
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
- |
200KNew |
$2.95M - $5.16M
|
200K
$520K
|
|
Nov 14, 2022
Q3 2022
|
Ghost Tree Capital, LLC
New York, NY |
BUY
|
- |
150KNew |
$2.22M - $3.87M
|
150K
$390K
|
|
Nov 14, 2022
Q3 2022
|
Lynx1 Capital Management LP
San Juan, PR |
BUY
|
- |
84.9K+ 44.31% |
$1.25M - $2.19M
|
276K
$719K
|
|
Nov 14, 2022
Q3 2022
|
Tcg Crossover Management, LLC
Palo Alto, CA |
BUY
|
- |
70K+ 7.87% |
$1.03M - $1.81M
|
960K
$2.49M
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
59.6K+ 247.5% |
$880K - $1.54M
|
83.6K
$217K
|
|
Nov 14, 2022
Q3 2022
|
Altium Capital Management LP
New York, NY |
BUY
|
- |
51KNew |
$753K - $1.32M
|
51K
$133K
|
|
Nov 14, 2022
Q3 2022
|
Driehaus Capital Management LLC
Chicago, IL |
BUY
|
- |
46.9KNew |
$692K - $1.21M
|
46.9K
$122K
|
|
Nov 14, 2022
Q3 2022
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
- |
35.8KNew |
$528K - $922K
|
35.8K
$93K
|
|
Nov 14, 2022
Q3 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
BUY
|
- |
34.3KNew |
$507K - $884K
|
34.3K
$89.2K
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
23.8K+ 5.39% |
$352K - $615K
|
466K
$1.21M
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
23.6K+ 1.48% |
$348K - $608K
|
1.62M
$4.2M
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
23.6K+ 1.48% |
$348K - $608K
|
1.62M
$4.2M
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
10.7K+ 526.64% |
$158K - $276K
|
12.7K
$33.1K
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
10.1K+ 1.43% |
$149K - $260K
|
715K
$1.86M
|
|
Nov 14, 2022
Q3 2022
|
Fred Alger Management, LLC
New York, NY |
BUY
|
- |
9.58K+ 5.54% |
$141K - $247K
|
182K
$474K
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
3.44K+ 2.07% |
$50.8K - $88.6K
|
170K
$441K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
2.93K+ 569.71% |
$43.3K - $75.7K
|
3.45K
$8.97K
|
|
Nov 08, 2022
Q3 2022
|
New York State Common Retirement Fund
|
BUY
|
- |
2.5K+ 48.21% |
$36.9K - $64.5K
|
7.69K
$20K
|
|
Nov 14, 2022
Q3 2022
|
Bank Of New York Mellon Corp
New York, NY |
BUY
|
- |
2.48K+ 9.89% |
$36.6K - $63.9K
|
27.5K
$71.6K
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
1.61KNew |
$23.8K - $41.6K
|
1.61K
$4.19K
|
|
Nov 10, 2022
Q3 2022
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
949+ 7.19% |
$14K - $24.5K
|
14.1K
$36.8K
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
948+ 16.13% |
$14K - $24.4K
|
6.82K
$17.7K
|
|
Nov 14, 2022
Q3 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
395+ 759.62% |
$5.83K - $10.2K
|
447
$1.16K
|
|
Nov 14, 2022
Q3 2022
|
Legal & General Group PLC
London, X0 |
BUY
|
- |
360+ 86.96% |
$5.32K - $9.28K
|
774
$2.01K
|
|
Oct 21, 2022
Q3 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
229New |
$3.38K - $5.91K
|
229
$595
|
|
Nov 14, 2022
Q3 2022
|
American International Group, Inc.
New York, NY |
BUY
|
- |
63+ 1.47% |
$931 - $1.62K
|
4.36K
$11.3K
|
|
Nov 10, 2022
Q3 2022
|
Credit Suisse Ag
Zurich, V8 |
BUY
|
- |
39+ 354.55% |
$576 - $1.01K
|
50
$130
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 02, 2022
Q3 2022
|
Ellevest, Inc.
|
SELL
|
- |
-12- 92.31% |
$177 - $309
|
1
$2.6
|
|
Nov 14, 2022
Q3 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-80- 0.34% |
$1.18K - $2.06K
|
23.8K
$61.8K
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-90- 76.27% |
$1.33K - $2.32K
|
28
$72.8
|
|
Nov 18, 2022
Q3 2022
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-302- 7.69% |
$4.46K - $7.79K
|
3.63K
$9.43K
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
SELL
|
- |
-570- 52.88% |
$8.42K - $14.7K
|
508
$1.32K
|
|
Nov 14, 2022
Q3 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-620- 14.28% |
$9.16K - $16K
|
3.72K
$9.68K
|
|
Nov 04, 2022
Q3 2022
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-881- 42.85% |
$13K - $22.7K
|
1.18K
$3.06K
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-1.31K- 1.72% |
$19.4K - $33.8K
|
74.8K
$195K
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.17K- 39.92% |
$46.7K - $81.6K
|
4.76K
$12.4K
|
|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-3.64K- 90.33% |
$53.7K - $93.7K
|
389
$1.01K
|
|
Nov 14, 2022
Q3 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-3.81K- 9.83% |
$56.3K - $98.3K
|
35K
$90.9K
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-5.38K- 3.01% |
$79.4K - $139K
|
173K
$450K
|
|
Nov 14, 2022
Q3 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-7.43K- 41.26% |
$110K - $192K
|
10.6K
$27.5K
|
|
Nov 14, 2022
Q3 2022
|
Parkwood LLC
Cleveland, OH |
SELL
|
- |
-11.1K- 34.15% |
$164K - $285K
|
21.3K
$55.5K
|
|
Nov 14, 2022
Q3 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-20K- 20.0% |
$295K - $516K
|
80K
$208K
|
|
Nov 14, 2022
Q3 2022
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-90.4K- 4.37% |
$1.34M - $2.33M
|
1.98M
$5.15M
|
|
Nov 09, 2022
Q3 2022
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-310K- 11.76% |
$4.58M - $8M
|
2.33M
$6.05M
|